• E-mail
• Print
• Comment
• Font Size
• Digg
• del.icio.us
• Discuss article

The Implementation of the Single-Child Policy in China Has Seen Particularly High Spending Per Child With OTC Healthcare Products Reaping the Benefits

Posted on: Friday, 24 February 2006, 06:00 CST

Research and Markets (http://www.researchandmarkets.com/reports/c33606) has announced the addition of Eye Care in China to their offering.

Over the review period of this report child-specific OTC healthcare products demonstrated the best performance within the OTC healthcare market, increasing by almost 18% in current value terms on 2003. The implementation of single-child policy in China has seen doting parents lavishing utmost care on their single child, with particularly high spending-per-child. In conjunction with growing product awareness and stricter quality control on drugs, parents are now more comfortable purchasing OTC healthcare products for their children.

This Eye Care in China report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data (1999-2004), allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, distribution or pricing issues. Forecasts to 2009 illustrate how the market is set to change.

Product coverage includes standard eye care and allergy eye care. Data coverage includes market sizes (historic and forecasts), company shares, brand shares.

Why read this report?

-- Get a detailed picture of the eye care industry

-- Pinpoint growth sectors and trends and identify factors

driving change

-- Understand the competitive environment, the market's major

players and leading brands

-- Use five-year forecasts to assess how the market is predicted

to develop

Companies Mentioned Include: - Amway (China) Co Ltd - Qingdao Jiante Biological Investment Co Ltd - Bristol-Myers Squibb (Shanghai) Trading Co Ltd - Wyeth-Whitehall Pharmaceutical Inc - Joincare Pharmaceutical Group Industry Co Ltd - Harbin Pharmaceutical Group - Shandong Dong-E E-Jiao Co Ltd - Shanghai Johnson & Johnson Pharmaceutical Ltd - Minsheng Pharm - Dyne Pharm Co Ltd - Xian Janssen Pharmaceutical Ltd - Shanghai Jiaoda Onlly Co Ltd - Guangxi Jin Sang Zi Pharm Co - Panlong Yunhai Pharmaceutical Corporation - Vital (Sichuan) Biotech Ltd - Guangxi Guilin Sanjin Medicine Group - Xiamen Xinsha Group Co Ltd - Jiangxi Hui Ren Group Co Ltd - Guangdong Shunde Hong Fu Loi - Healthcare Product Co Ltd - RHK (Group) Co Ltd - GlaxoSmithKline (Tianjin) Pharm Co Ltd - Jiangzhong Pharmaceutical Co - Sanjiu Enterprise Group - Xiamen Goldsun Pharm Co Ltd - Yangshengtang Co Ltd - Mentholatum (Zhongshan) Pharmaceuticals Co Ltd, The - Jilin Gankang Pharmaceutical Co Ltd - Chengdu Ju Neng Industrial Co Ltd - Beijing Zizu Pharm Co Ltd - Jiangsu Qidong Gaitianli Pharm Co Ltd - Nin Jiom Medicine Mfy (Hong Kong) Ltd - Beijing Double Crane Pharm Co Ltd - Shenzhen WanJi Pharm Co Ltd - Wuhan Ma Ying Long Pharm Group - Shanghai Yanan Wanxiang Pharmaceutical Co Ltd - Shandong C-P Freda Pharm - Guangdong Shunfeng Pharm - Shanghai Heng Shou Tang Pharm Co Ltd - Jilin Xiuzheng Pharmaceutical Co Ltd - Shanghai Roche Pharm Ltd - Harbin Taihua Pharm Co Ltd - Beijing Four Rings Pharmaceutical Co Ltd - Shanghai Schering-Plough Pharm Co Ltd - Shenyang No 1 Pharm Fty - Boots Co Plc, The - Hebei Hengli Pharm Co Ltd - Shanghai Green Valley Group Co Ltd - Hainan Asia Medicine Co Ltd - Shanxi Guilong Medicine Co Ltd - Beijing Novartis Pharma Ltd - Hubei Meisheng pharmaceutical Co Ltd - Reckitt Benckiser China - Suntory Ltd - Xiamen Dongfeng Pharm Co Ltd - Guangzhou Pan Gao Shou Pharm Co - Guizhou Shenqi Pharm Co Ltd - Shenzhen Neptunus Group Co Ltd - Beijing No 1 Pharm Co Ltd - Bayer AG - Sichuan Fuling Pharm Co - Shanghai K-Max Health Products Co Ltd - Wuhan Tiantian Pharmaceutical Co Ltd - Zhejiang Hai Li Sheng Pharm - Luxembourgh Medicine Co Ltd, The - Guangdong Medtech Xinghua Pharmaceutical Co Ltd - Wuhan Jianmin Pharm Group Co Ltd - Fortune Pharmacal Co Ltd - Nature's Way Inc - Yunnan Baiyao Group Co Ltd - Guizhou Yibai Pharm Co Ltd - Guangxi Northsea Pearl Co Ltd - Zhuhai United Pharm Co Ltd - Beijing Tong Ren Tang Pharmaceutical Co Ltd - Xiamen Leephick Pharm Co Ltd - Hangzhou Hu Qing Yu Tang Pharmaceutical Co Ltd - Yiantai Rong Chang Pharm - Zhejiang Ruibang Laboratories - Suzhou Tianlong Medical - Healthcare Co Ltd - Fujian Shun-Shun Pharmaceutical Ltd - Scientific Light Pharautial Guizhou - Santen Pharmaceutical Co Ltd - Tangshan Tianen Pharm Co Ltd - Shanghai Nycomed Pharmaceutical Co Ltd - Guangzhou Jing Xiu Tang Pharm Co Ltd - Guizhou Convene Pharm - Shenzhen Tai Tai Pharmaceutical Co Ltd - Health Food Enterprise Ltd - Hi-Yeah International - Enterprise Group - Beijing Tongrentang Group Co Ltd - GlaxoSmithKline (Tianjin) Pharm Co Ltd - Shanghai Roche Pharm Co Ltd - Shanghai Squibb Pharmaceuticals Ltd

For more information visit http://www.researchandmarkets.com/reports/c33606

Source: Business Wire

More News in this Category